Status:
COMPLETED
Identifying the Role of Symptom Outcomes and Biomarkers in Survival in Patients With Metastatic Pancreatic Cancer
Lead Sponsor:
M.D. Anderson Cancer Center
Conditions:
Pancreatic Cancer
Eligibility:
All Genders
18+ years
Brief Summary
The goal of this clinical research study is to learn about symptoms related to chemotherapy and the disease, in patients with advanced pancreatic cancer. Researchers will study the possible reason for...
Detailed Description
Researchers want to try to improve patient care for advanced pancreatic cancer by looking at how some symptoms create a great burden on daily life. They also want to find out which "markers" in the bl...
Eligibility Criteria
Inclusion
- Patients must have histologically or cytologically confirmed cancer of the pancreas.
- Patients must have inoperable locally advanced or metastatic disease.
- Patients could be on treatment, or being planned for chemotherapy treatment.
- Age 18 years of age or older
- ECOG performance status 0-3
- Ability to give consent in either English or Spanish
Exclusion
- Any condition (including unwillingness) that would impair the patient's ability to utilize the IVR system
- Any recent surgical procedures (within 14 days, excluding biopsy, port-a-cath or picc line placement)
Key Trial Info
Start Date :
November 12 2008
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
February 27 2018
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT00805688
Start Date
November 12 2008
End Date
February 27 2018
Last Update
March 6 2018
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Texas MD Anderson Cancer Center
Houston, Texas, United States, 77030